Fresenius Medical Care AG KGaA ROE 2010-2023 | FMS
Current and historical return on equity (ROE) values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Fresenius Medical Care AG KGaA ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $0.54B | $16.05B | 3.31% |
| 2023-09-30 | $0.48B | $16.80B | 2.94% |
| 2023-06-30 | $0.62B | $16.28B | 3.79% |
| 2023-03-31 | $0.63B | $16.35B | 3.80% |
| 2022-12-31 | $0.71B | $16.28B | 4.32% |
| 2022-09-30 | $0.83B | $16.86B | 5.00% |
| 2022-06-30 | $0.92B | $16.44B | 5.63% |
| 2022-03-31 | $1.02B | $16.32B | 6.38% |
| 2021-12-31 | $1.15B | $16.54B | 7.19% |
| 2021-09-30 | $1.10B | $15.86B | 7.20% |
| 2021-06-30 | $1.19B | $15.44B | 7.93% |
| 2021-03-31 | $1.32B | $15.91B | 8.86% |
| 2020-12-31 | $1.33B | $14.09B | 9.14% |
| 2020-09-30 | $1.49B | $14.80B | 10.13% |
| 2020-06-30 | $1.45B | $14.67B | 9.79% |
| 2020-03-31 | $1.35B | $14.64B | 9.15% |
| 2019-12-31 | $1.34B | $14.82B | 9.07% |
| 2019-09-30 | $1.45B | $15.06B | 9.68% |
| 2019-06-30 | $1.41B | $14.39B | 9.53% |
| 2019-03-31 | $2.31B | $15.02B | 15.66% |
| 2018-12-31 | $2.34B | $15.24B | 16.34% |
| 2018-09-30 | $2.32B | $14.36B | 17.07% |
| 2018-06-30 | $2.35B | $14.29B | 17.90% |
| 2018-03-31 | $1.46B | $13.41B | 11.69% |
| 2017-12-31 | $1.45B | $12.24B | 11.90% |
| 2017-09-30 | $1.38B | $12.54B | 11.51% |
| 2017-06-30 | $1.35B | $11.76B | 11.57% |
| 2017-03-31 | $1.34B | $12.04B | 11.79% |
| 2016-12-31 | $1.24B | $11.46B | 11.22% |
| 2016-09-30 | $1.17B | $11.24B | 10.81% |
| 2016-06-30 | $1.10B | $10.83B | 10.39% |
| 2016-03-31 | $1.05B | $10.81B | 9.99% |
| 2015-12-31 | $1.03B | $10.50B | 9.92% |
| 2015-09-30 | $1.05B | $10.24B | 10.20% |
| 2015-06-30 | $1.06B | $10.43B | 10.22% |
| 2015-03-31 | $1.05B | $10.38B | 10.18% |
| 2014-12-31 | $1.05B | $10.03B | 10.15% |
| 2014-09-30 | $1.06B | $10.52B | 10.26% |
| 2014-06-30 | $1.06B | $10.32B | 10.48% |
| 2014-03-31 | $1.09B | $10.31B | 10.95% |
| 2013-12-31 | $1.11B | $10.13B | 11.26% |
| 2013-09-30 | $1.02B | $9.74B | 10.44% |
| 2013-06-30 | $1.02B | $9.65B | 10.49% |
| 2013-03-31 | $1.04B | $9.90B | 10.94% |
| 2012-12-31 | $1.19B | $9.73B | 12.71% |
| 2012-09-30 | $1.24B | $9.44B | 13.74% |
| 2012-06-30 | $1.25B | $9.01B | 14.33% |
| 2012-03-31 | $1.22B | $9.14B | 14.33% |
| 2011-12-31 | $1.07B | $8.47B | 13.06% |
| 2011-09-30 | $1.03B | $8.22B | 12.85% |
| 2011-06-30 | $1.00B | $8.23B | 12.76% |
| 2011-03-31 | $0.99B | $7.88B | 13.14% |
| 2010-12-31 | $0.98B | $7.80B | 13.34% |
| 2010-09-30 | $0.95B | $7.47B | 13.36% |
| 2010-06-30 | $0.93B | $6.93B | 13.40% |
| 2010-03-31 | $0.90B | $7.13B | 13.27% |
| 2009-12-31 | $0.89B | $7.03B | 13.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.452B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
| Edwards Lifesciences (EW) | United States | $50.799B | 33.06 |
| DexCom (DXCM) | United States | $50.060B | 75.83 |
| IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
| Alcon (ALC) | Switzerland | $38.723B | 28.56 |
| STERIS (STE) | Ireland | $20.261B | 23.98 |
| Waters (WAT) | United States | $18.737B | 26.89 |
| Hologic (HOLX) | United States | $17.905B | 19.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
| Teleflex (TFX) | United States | $9.964B | 15.65 |
| Penumbra (PEN) | United States | $7.957B | 98.22 |
| Masimo (MASI) | United States | $7.091B | 39.77 |
| Globus Medical (GMED) | United States | $6.827B | 21.64 |
| Glaukos (GKOS) | United States | $4.964B | 0.00 |
| TransMedics (TMDX) | United States | $3.847B | 367.50 |
| Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
| LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
| Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
| Inari Medical (NARI) | United States | $2.419B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
| RxSight (RXST) | United States | $2.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
| Veracyte (VCYT) | United States | $1.539B | 0.00 |
| OPKO Health (OPK) | United States | $0.885B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
| Artivion (AORT) | United States | $0.838B | 96.81 |
| Paragon 28 (FNA) | United States | $0.817B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
| IRadimed (IRMD) | United States | $0.532B | 30.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
| AxoGen (AXGN) | United States | $0.287B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
| Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.087B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |